Clinical Research, Pharma & Healthcare FinancingSyremis Therapeutics Raises $165M for Mental Health DrugsBusiness WireDecember 19, 2025December 23, 2025 by Business WireDecember 19, 2025December 23, 2025030 Addressing major unmet needs in mental health with pharmacology rooted in emerging and clinically validated neuropsychiatric biology Lead program ST-905, a potent M1/M4 muscarinic agonist,...
